Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'factor VIII' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2172 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Smales, CM; Pepper, DS; James, DC
      Protein modifications during antiviral heat bioprocessing and subsequent storage

      BIOTECHNOLOGY PROGRESS
    2. Chang, TJ; Mohamed, S; Hambleton, J
      Hemophilic arthropathy: Considerations in management

      JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION
    3. Chao, HJ; Monahan, PE; Liu, YB; Samulski, RJ; Walsh, CE
      Sustained and complete phenotype correction of hemophilia B mice followingintramuscular injection of AAV1 serotype vectors

      MOLECULAR THERAPY
    4. McCormack, JE; Edwards, W; Sensintaffer, J; Lillegren, L; Kozloski, M; Brumm, D; Karavodin, L; Jolly, DJ; Greengard, J
      Factors affecting long-term expression of a secreted transgene product after intravenous administration of a retroviral vector

      MOLECULAR THERAPY
    5. Lipshutz, GS; Gruber, CA; Cao, YA; Hardy, J; Contag, CH; Gaensler, KML
      In utero delivery of adeno-associated viral vectors: Intraperitoneal gene transfer produces long-term expression

      MOLECULAR THERAPY
    6. de Wit, TR; van Mourik, JA
      Biosynthesis, processing and secretion of von Willebrand factor: biological implications

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    7. Ruggeri, ZM
      Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    8. Favaloro, EJ
      Appropriate laboratory assessment as a critical facet in the proper diagnosis and classification of von Willebrand disorder

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    9. Rodeghiero, F; Castaman, G
      Congenital von Willebrand disease type I: definition, phenotypes, clinicaland laboratory assessment

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    10. Mazurier, C; Goudemand, J; Hilbert, L; Caron, C; Fressinaud, E; Meyer, D
      Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    11. Eikenboom, JCJ
      Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    12. Michiels, JJ; Budde, U; van der Planken, M; van Vliet, HHDM; Schroyens, W; Berneman, Z
      Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    13. Mannucci, PM; Federici, AB
      Management of inherited von Willebrand disease

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    14. Emanuel, BS; Shaikh, TH
      Segmental duplications: An 'expanding' role in genomic instability and disease

      NATURE REVIEWS GENETICS
    15. Schmaldienst, S; Mullner, M; Goldammer, A; Spitzauer, S; Banyai, S; Horl, WH; Derfler, K
      Intravenous immunoglobulin application following immunoadsorption: benefitor risk in patients with autoimmune diseases?

      RHEUMATOLOGY
    16. Illert, WE; Butsch, H; Nuber, D; Howe, J; Sanger, W; Weidinger, S
      Long-term storage multicenter study of fresh frozen plasma at -40 degrees C. A multicenter study on the stability of labile coagulation factors over a period of 3 years

      INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    17. Grimm, DR; Colter, MB; Braunschweig, M; Alexander, LJ; Neame, PJ; Kim, HKW
      Porcine factor V: cDNA cloning, gene mapping, three-dimensional protein modeling of membrane binding sites and comparative anatomy of domains

      CELLULAR AND MOLECULAR LIFE SCIENCES
    18. Josic, D; Buchacher, A; Jungbauer, A
      Monoliths as stationary phases for separation of proteins and polynucleotides and enzymatic conversion

      JOURNAL OF CHROMATOGRAPHY B
    19. Pflegerl, K; Hahn, R; Schallaun, E; Josic, D; Jungbauer, A
      Quantification of plasma-derived blood coagulation factor VIII by real-time biosensor measurements

      JOURNAL OF CHROMATOGRAPHY B
    20. Liras, A
      Gene therapy for haemophilia: the end of a 'royal pathology' in the third millennium?

      HAEMOPHILIA
    21. Fischer, K; Van der Bom, JG; Mauser-Bunschoten, EP; Roosendaal, G; Prejs, R; Grobbee, DE; Van den Berg, HM
      Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy

      HAEMOPHILIA
    22. Miners, AH; Sabin, CA; Tolley, KH; Parnaby, A; Lee, CA
      Assessing the relationship between productivity levels and severity of haemophilia

      HAEMOPHILIA
    23. Timur, AA; Gurgey, A; Aktuglu, G; Kavakli, K; Canatan, D; Olek, K; Caglayan, SH
      Molecular pathology of haemophilia A in Turkish patients: identification of 36 independent mutations

      HAEMOPHILIA
    24. Zanon, E; Vianello, F; Casonato, A; Girolami, A
      Early transfusion of factor VIII/von Willebrand factor concentrates seems to be effective in the treatment of gatrointestinal bleeding in patients with von Willebrand type III disease

      HAEMOPHILIA
    25. Meiklejohn, DJ; Watson, HG
      Acquired haemophilia in association with organ-specific autoimmune disease

      HAEMOPHILIA
    26. Makris, M; Baglin, T; Dusheiko, G; Giangrande, PLF; Lee, CA; Ludlam, CA; Preston, FE; Watson, HG; Wilde, JT; Winter, M
      Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia

      HAEMOPHILIA
    27. Scharrer, I; Ehrlich, HJ
      Lack of evidence for increased inhibitor incidence in patients switched from plasma-derived to recombinant factor VIII

      HAEMOPHILIA
    28. Rizza, CR; Hill, FGH; Spooner, RJD; Giangrande, PLF
      Treatment of haemophilia in the United Kingdom 1981-1996

      HAEMOPHILIA
    29. Berntorp, E; Petrini, P; Dockter, G; Tengborn, L; Wendisch, I; Eberl, W; Aumann, V; Frade, G; Seliger, I; Engl, W; Ehrlich, H
      An approach to study the viral safety of plasma-derived products in previously treated, non-infected patients

      HAEMOPHILIA
    30. Mauser-Bunschoten, EP; van der Bom, JG; Bongers, M; Twijnstra, M; Roosendaal, G; Fischer, K; van den Berg, HM
      Purity of factor VIII product and incidence of inhibitors in previously untreated patients with haemophilia A

      HAEMOPHILIA
    31. Kallas, A; Talpsep, T
      von Willebrand factor in factor VIII concentrates protects against neutralization by factor VIII antibodies of haemophilia A patients

      HAEMOPHILIA
    32. Theophilus, BDM; Enayat, MS; Williams, MD; Hill, FGH
      Site and type of mutations in the factor VIII gene in patients and carriers of haemophilia A

      HAEMOPHILIA
    33. Acquila, M; Bottini, F; Valetto, A; Caprino, D; Mori, PG; Bicocchi, MP
      A new strategy for prenatal diagnosis in a sporadic haemophilia B family

      HAEMOPHILIA
    34. Mazzucconi, MG; Bizzoni, L; Giorgi, A; Morano, SG; Peraino, M; Russo, M; Alimena, G
      Postpartum inhibitor to factor VIII: treatment with high-dose immunoglobulin and dexamethasone

      HAEMOPHILIA
    35. Godreuil, S; Navarro, R; Quittet, P; Landreau, L; Schved, JF; Biron-Andreani, C
      Acquired haemophilia in the elderly is a severe disease: report of five new cases

      HAEMOPHILIA
    36. Cohen, AJ; Kessler, CM; Ewenstein, BM
      Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America

      HAEMOPHILIA
    37. Yoshioka, A; Shima, M; Fukutake, K; Takamatsu, J; Shirahata, A
      Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII-FS) in patients with haemophilia A: a long-term, multicentre clinical study in Japan

      HAEMOPHILIA
    38. Leissinger, C; Becton, D; Cornell, C; Gill, JC
      High-dose DDAVP intranasal spray (Stimate((R))) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A

      HAEMOPHILIA
    39. Astermark, J; Berntorp, E; White, GC; Kroner, BL
      The Malmo International Brother Study (MIBS): further support for genetic predisposition to inhibitor development

      HAEMOPHILIA
    40. Ghosh, K; Shetty, S; Kulkarni, B; Nair, S; Pawar, A; Khare, A; Baindur, S; Mohanty, D
      Development of inhibitors in patients with haemophilia from India

      HAEMOPHILIA
    41. Klein, I; Andrikovics, H; Bors, A; Nemes, L; Tordai, A; Varadi, A
      A haemophilia A and B molecular genetic diagnostic programme in Hungary: ahighly informative and cost-effective strategy

      HAEMOPHILIA
    42. Faradji, A; Bonnomet, F; Lecocq, J; Grunebaum, L; Desprez, D; Kern, O; Barbier, L; Sibilia, J
      Knee joint arthroplasty in a patient with haemophilia A and high inhibitortitre using recombinant factor VIIa (NovoSeven((R))): a new case report and review of the literature

      HAEMOPHILIA
    43. Kashyap, R; Choudhry, VP; Mahapatra, M; Chumber, S; Saxena, R; Kaul, HL
      Postpartum acquired haemophilia: clinical recognition and management

      HAEMOPHILIA
    44. Samaiya, A; Gupta, S; Chumber, S; Kashyap, R; Dewanda, NK; Vashisht, S; Choudhry, VP
      Blunt abdominal trauma with delayed rupture of splenic haematoma in a haemophiliac patient

      HAEMOPHILIA
    45. Yenchitsomanus, P; Thanootarakul, P; Akkarapatumwong, V; Oranwiroon, S; Pung-Amritt, P; Veerakul, G; Mahasandana, C
      Mutation causing exon 15 skipping and partial exon 16 deletion in factor VIII transcript, and a method for direct mutation detection

      HAEMOPHILIA
    46. Bjorkman, S; Shapiro, AD; Berntorp, E
      Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis

      HAEMOPHILIA
    47. Haya, S; Lopez, MF; Aznar, JA; Batlle, J
      Immune tolerance treatment in haemophilia patients with inhibitors: the Spanish Registry

      HAEMOPHILIA
    48. Dykes, AC; Walker, ID; Lowe, GDO; Tait, RC
      Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review

      HAEMOPHILIA
    49. Grunewald, M; Beneke, H; Guthner, C; Germowitz, A; Brommer, A; Griesshammer, M
      Acquired haemophilia: experiences with a standardized approach

      HAEMOPHILIA
    50. Soucie, JM; Symons, J; Evatt, B; Brettler, D; Huszti, H; Linden, J
      Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia

      HAEMOPHILIA
    51. Mondorf, W; Klinge, J; Luban, NLC; Bray, G; Saenko, E; Scandella, D
      Low factor VIII recovery in haemophilia A patients without inhibitor titreis not due to the presence of anti-factor VIII antibodies undetectable by the Bethesda assay

      HAEMOPHILIA
    52. Oranwiroon, S; Akkarapatumwong, V; Pung-Amritt, P; Treesucon, A; Veerakul, G; Mahasandana, C; Panyim, S; Yenchitsomanus, P
      Determination of haemophilia A carrier status by mutation analysis

      HAEMOPHILIA
    53. Calvez, T; Biou, M; Costagliola, D; Jullien, AM; Laurian, Y; Rossi, F; Rothschild, C; Sie, P
      The French haemophilia cohort: rationale and organization of a long-term national pharmacosurveillance system

      HAEMOPHILIA
    54. Miller, R
      The responsibility of separating truth from myth to patient and family

      HAEMOPHILIA
    55. Mauser-Bunschoten, EP; Roosendaal, G; Van den Berg, HM
      Product choice and haemophilia treatment in the Netherlands

      HAEMOPHILIA
    56. Berntorp, E
      Immune tolerance induction: recombinant vs. human-derived product

      HAEMOPHILIA
    57. Aledort, LM
      Making a therapeutic choice: human versus recombinant fractions - can we do it?

      HAEMOPHILIA
    58. Hoots, WK
      The future of plasma-derived clotting factor concentrates

      HAEMOPHILIA
    59. Ewenstein, BM
      Use of ristocetin cofactor activity in the management of von Willebrand disease

      HAEMOPHILIA
    60. High, KA
      Gene therapy: a 2001 perspective

      HAEMOPHILIA
    61. Ragni, MV
      New-generation recombinant factor concentrates: bridge to gene therapy

      HAEMOPHILIA
    62. Alberth, G; Kettisen, J; Lisander, B
      Blood loss in prosthetic hip replacement is not influenced by the AB0 blood group

      EUROPEAN JOURNAL OF SURGERY
    63. Turgeman, G; Pittman, DD; Muller, R; Kurkalli, BG; Zhou, SH; Pelled, G; Peyser, A; Zilberman, Y; Moutsatsos, IK; Gazit, D
      Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy

      JOURNAL OF GENE MEDICINE
    64. Sarukhan, A; Soudais, C; Danos, O; Jooss, K
      F;actors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors

      JOURNAL OF GENE MEDICINE
    65. Chuah, MKL; Collen, D; VandenDriessche, T
      Gene therapy for hemophilia

      JOURNAL OF GENE MEDICINE
    66. Kamphuisen, PW; Eikenboom, JCJ; Bertina, RM
      Elevated factor VIII levels and the risk of thrombosis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    67. Schambeck, CM; Hinney, K; Haubitz, I; Taleghani, BM; Wahler, D; Keller, F
      Familial clustering of high factor VIII levels in patients with venous thromboembolism

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    68. Sumner, M; Suiter, T
      Accuracy about coagulation products

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    69. Shord, SS; Lindley, C
      Accuracy about coagulation products

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    70. Michiels, JJ; Schroyens, W; Berneman, Z; van der Planken, S
      Atypical variant of acquired von Willebrand syndrome in Wilms tumor: Is hyaluronic acid secreted by nephroblastoma cells the cause?

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    71. Michiels, JJ; Schroyens, W; van der Planken, M; Berneman, Z
      Acquired von Willebrand syndrome in systemic lupus erythematodes

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    72. Kagawa, H; Nomura, S; Nagahama, M; Ozaki, Y; Fukuhara, S
      Effect of bezafibrate on soluble adhesion molecules and platelet activation markers in patients with connective tissue diseases and secondary hyperlipidemia

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    73. Cavazzana-Calvo, M; Hacein-Bey-Abina, S
      Correction of genetic blood defects by gene transfer

      CURRENT OPINION IN HEMATOLOGY
    74. Hambleton, J
      Diagnosis and incidence of inherited von Willebrand disease

      CURRENT OPINION IN HEMATOLOGY
    75. Dahm, T; White, J; Grill, S; Fullekrug, J; Stelzer, EHK
      Quantitative ER <-> Golgi transport kinetics and protein separation upon Golgi exit revealed by vesicular integral membrane protein 36 dynamics in live cells

      MOLECULAR BIOLOGY OF THE CELL
    76. Burggraaf, J; Lalezari, S; Emeis, JJ; Vischer, UM; de Meyer, PHEM; Pijl, H; Cohen, AF
      Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol

      THYROID
    77. Bristol, JA; Gallo-Penn, A; Andrews, J; Idamakanti, N; Kaleko, M; Connelly, S
      Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia a mice compared with factor VIII protein infusion

      HUMAN GENE THERAPY
    78. Shetty, S; Ghosh, K; Bhide, A; Mohanty, D
      Carrier detection and prenatal diagnosis in families with haemophilia

      NATIONAL MEDICAL JOURNAL OF INDIA
    79. Fields, PA; Armstrong, E; Hagstrom, JN; Arruda, VR; Murphy, ML; Farrell, JP; High, KA; Herzog, RW
      Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice

      GENE THERAPY
    80. Aradhya, S; Bardaro, T; Galgoczy, P; Yamagata, T; Esposito, T; Patlan, H; Ciccodicola, A; Munnich, A; Kenwrick, S; Platzer, M; D'Urso, M; Nelson, DL
      Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes

      HUMAN MOLECULAR GENETICS
    81. Aradhya, S; Woffendin, H; Jakins, T; Bardaro, T; Esposito, T; Smahi, A; Shaw, C; Levy, M; Munnich, A; D'Urso, M; Lewis, RA; Kenwrick, S; Nelson, DL
      A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations

      HUMAN MOLECULAR GENETICS
    82. Meyer, DL; Schultz, J; Lin, YK; Henry, A; Sanderson, J; Jackson, JM; Goshorn, S; Rees, AR; Graves, SS
      Reduced antibody response to streptavidin through site-directed mutagenesis

      PROTEIN SCIENCE
    83. Hornsey, VS; Drummond, O; Young, D; Docherty, A; Prowse, CV
      A potentially improved approach to methylene blue virus inactivation of plasma: the Maco Pharma Maco-Tronic system

      TRANSFUSION MEDICINE
    84. Melton, LG; Li, T; Stafford, DW; Gabriel, DA
      Location of the platelet binding site in zymogen coagulation factor IX

      BLOOD COAGULATION & FIBRINOLYSIS
    85. Kramoroff, A; Nigretto, JM
      In vitro factor XI activation mechanism according to an optimized model ofactivated partial thromboplastin time test

      BLOOD COAGULATION & FIBRINOLYSIS
    86. Chitolie, A; Lawrie, AS; Mackie, IJ; Harrison, P; Machin, SJ
      The impact of oral anticoagulant therapy, factor VIII level and quality offactor V-deficient plasma on three commercial methods for activated protein C resistance

      BLOOD COAGULATION & FIBRINOLYSIS
    87. Yngen, M; Ostenson, CG; Li, N; Hjemdahl, P; Wallen, NH
      Acute hyperglycemia increases soluble P-selectin in male patients with mild diabetes mellitus

      BLOOD COAGULATION & FIBRINOLYSIS
    88. Smales, CM; Pepper, DS; James, DC
      Evaluation of protein modification during anti-viral heat bioprocessing byelectrospray ionization mass spectrometry

      RAPID COMMUNICATIONS IN MASS SPECTROMETRY
    89. Kallas, A; Talpsep, T
      The von Willebrand factor collagen-binding activity assay: clinical application

      ANNALS OF HEMATOLOGY
    90. Dansako, H; Ishimaru, F; Takai, Y; Tomoda, J; Nakase, K; Fujii, K; Ogama, Y; Kozuka, T; Sezaki, N; Honda, K; Harada, M
      Molecular characterization of the ERGIC-53 gene in two Japanese patients with combined factor V-factor VIII deficiency

      ANNALS OF HEMATOLOGY
    91. Shwaiki, A; Lara, L; Ahmed, F; Crock, R; Rutecki, GW; Whittier, FC
      Acquired inhibitor to factor VIII in small cell lung cancer: a case reportand review of the literature

      ANNALS OF HEMATOLOGY
    92. Theodossiades, G; Tsevrenis, N; Nomikou, E; Dadiotis, L; Kontopoulou-Griva, I
      Surgery-associated acquired hemophilia A

      ANNALS OF HEMATOLOGY
    93. Kinoshita, S; Yoshioka, A; Park, YD; Ishizashi, H; Konno, M; Funato, M; Matsui, T; Titani, K; Yagi, H; Matsumoto, M; Fujimura, Y
      Upshaw-Schulman syndrome revisited: A concept of congenital thrombotic thrombocytopenic purpura

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    94. Sasahara, Y; Kumaki, S; Ohashi, Y; Minegishi, M; Kano, H; Bessho, F; Tsuchiya, S
      Deficient activity of von Willebrand factor-cleaving protease in patients with Upshaw-Schulman syndrome

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    95. Adler, Y; Attar, D; Vaturi, M; Golovchiner, G; Iakobishvili, Z; Battler, A; Siegel, RJ; Birnbaum, Y
      The effects of streptokinase and hydroxyethyl starch on in vitro clot disruption by ultrasound

      CARDIOVASCULAR DRUGS AND THERAPY
    96. Kawata, N; Yagasaki, H; Yuge, H; Nakanoya, Y; Fujimura, K; Sugimoto, S; Hirakata, H; Takimoto, Y
      Histopathologic analysis of angiogenic factors in localized renal cell carcinoma: The influence of neoadjuvant treatment

      INTERNATIONAL JOURNAL OF UROLOGY
    97. Ishikawa, T; Tsukamoto, N; Suto, M; Uchiumi, H; Mitsuhashi, H; Yokohama, A; Maesawa, A; Nojima, Y; Naruse, T
      Acquired hemophilia A in a patient with systemic lupus erythematosus

      INTERNAL MEDICINE
    98. Hall, RL; Leahy, MF
      Acquired Factor VIII autoantibody: four cases demonstrating the heterogenous nature of this condition and problems involved in diagnosis and treatment

      EUROPEAN JOURNAL OF HAEMATOLOGY
    99. Morgenthaler, JJ
      Securing viral safety for plasma derivatives

      TRANSFUSION MEDICINE REVIEWS
    100. Hoots, WK
      History of plasma-product safety

      TRANSFUSION MEDICINE REVIEWS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 00:19:28